Millennium Pharmacon International (SDPC) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.063x

Based on the latest financial reports, Millennium Pharmacon International (SDPC) has a cash flow conversion efficiency ratio of -0.063x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp-18.67 Billion ≈ $-1.09 Million USD) by net assets (Rp296.69 Billion ≈ $17.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Millennium Pharmacon International - Cash Flow Conversion Efficiency Trend (2004–2024)

This chart illustrates how Millennium Pharmacon International's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read SDPC current and long-term liabilities for a breakdown of total debt and financial obligations.

Millennium Pharmacon International Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Millennium Pharmacon International ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Les Hôtels de Paris SA PA:HDP	-0.102x
RECYCLICO BATTERY METALS F:ID4	N/A
MSCM Holdings Bhd KLSE:0041	-0.048x
Sequoia Econ Infrastructure LSE:SEQI	0.026x
Euromedis Groupe SA PA:ALEMG	0.048x
Turbo Mech Bhd KLSE:5167	0.025x
Bodycote PLC LSE:BOY	0.096x
Iconic Minerals Ltd V:ICM	-2.148x

Annual Cash Flow Conversion Efficiency for Millennium Pharmacon International (2004–2024)

The table below shows the annual cash flow conversion efficiency of Millennium Pharmacon International from 2004 to 2024. For the full company profile with market capitalisation and key ratios, see Millennium Pharmacon International (SDPC) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Rp282.50 Billion ≈ $16.55 Million	Rp-125.45 Billion ≈ $-7.35 Million	-0.444x	-34.56%
2023-12-31	Rp277.71 Billion ≈ $16.27 Million	Rp-91.65 Billion ≈ $-5.37 Million	-0.330x	-308.43%
2022-12-31	Rp258.91 Billion ≈ $15.17 Million	Rp41.00 Billion ≈ $2.40 Million	0.158x	+306.44%
2021-12-31	Rp236.98 Billion ≈ $13.89 Million	Rp-18.18 Billion ≈ $-1.07 Million	-0.077x	-124.52%
2020-12-31	Rp229.20 Billion ≈ $13.43 Million	Rp71.69 Billion ≈ $4.20 Million	0.313x	+391.54%
2019-12-31	Rp235.44 Billion ≈ $13.80 Million	Rp-25.26 Billion ≈ $-1.48 Million	-0.107x	-627.27%
2018-12-31	Rp232.11 Billion ≈ $13.60 Million	Rp4.72 Billion ≈ $276.75K	0.020x	-2.94%
2017-12-31	Rp212.61 Billion ≈ $12.46 Million	Rp4.46 Billion ≈ $261.18K	0.021x	+111.13%
2016-12-31	Rp143.28 Billion ≈ $8.40 Million	Rp-26.99 Billion ≈ $-1.58 Million	-0.188x	+63.20%
2015-12-31	Rp134.31 Billion ≈ $7.87 Million	Rp-68.74 Billion ≈ $-4.03 Million	-0.512x	-1218.86%
2014-12-31	Rp121.79 Billion ≈ $7.14 Million	Rp-4.73 Billion ≈ $-276.93K	-0.039x	+91.69%
2013-12-31	Rp114.87 Billion ≈ $6.73 Million	Rp-53.67 Billion ≈ $-3.14 Million	-0.467x	-2326.94%
2012-12-31	Rp104.62 Billion ≈ $6.13 Million	Rp2.19 Billion ≈ $128.61K	0.021x	+118.58%
2011-12-31	Rp94.78 Billion ≈ $5.55 Million	Rp-10.70 Billion ≈ $-626.92K	-0.113x	-273.40%
2007-12-31	Rp70.24 Billion ≈ $4.12 Million	Rp4.57 Billion ≈ $267.94K	0.065x	+391.77%
2006-12-31	Rp60.63 Billion ≈ $3.55 Million	Rp802.62 Million ≈ $47.03K	0.013x	-78.04%
2004-12-31	Rp45.18 Billion ≈ $2.65 Million	Rp2.72 Billion ≈ $159.57K	0.060x	--

About Millennium Pharmacon International

JK:SDPC Indonesia Medical Distribution

Market Cap

$14.11 Million

Rp240.79 Billion IDR

Market Cap Rank

#26014 Global

#590 in Indonesia

Share Price

Rp189.00

Change (1 day)

-1.56%

52-Week Range

Rp125.00 - Rp202.00

All Time High

Rp357.65